{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:58:32Z","timestamp":1773971912038,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022271","name":"Faculty of Veterinary Medicine, Kasetsart University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.biopha.2024.117600","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T06:59:57Z","timestamp":1730357997000},"page":"117600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Liposomal formulation with thiazolic compounds against bacterial efflux pumps"],"prefix":"10.1016","volume":"180","author":[{"given":"Ray Silva","family":"de Almeida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscilla Ramos","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Carolina","family":"Justino de Araujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saulo Relison","family":"Tintino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Ribeiro-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo Marinho","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo Miguel","family":"Sigueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila Alves","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diogo Teixeira","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiago Belarmino","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"La\u00eds Regina dos","family":"Santos Folquitto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle Ferreira","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5286-2249","authenticated-orcid":false,"given":"Ant\u00f3nio","family":"Raposo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariana","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6356-3001","authenticated-orcid":false,"given":"Heesup","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrique Douglas Melo","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.biopha.2024.117600_bib1","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202051034","article-title":"Antibiotic resistance and persistence\u2014Implications for human health and treatment perspectives","volume":"21","author":"Huemer","year":"2020","journal-title":"EMBO Rep."},{"issue":"3","key":"10.1016\/j.biopha.2024.117600_bib2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","article-title":"An overview of the antimicrobial resistance mechanisms of bacteria","volume":"4","author":"Reygaert","year":"2018","journal-title":"AIMS Microbiol"},{"issue":"7643","key":"10.1016\/j.biopha.2024.117600_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nature.2017.21550","article-title":"The drug-resistant bacteria that pose the greatest health threats","volume":"543","author":"Willyard","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2024.117600_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/AAC.50.1.43-48.2006","article-title":"Multidrug-Resistant Pseudomonas aeruginosa: Risk Factors and Clinical Impact","volume":"50","author":"Aloush","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.biopha.2024.117600_bib5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s40121-022-00591-2","article-title":"Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa","volume":"11","author":"Coyne","year":"2022","journal-title":"Infect. Dis. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2024.117600_bib6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41392-022-01056-1","article-title":"Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics","volume":"7","author":"Qin","year":"2022","journal-title":"Sig Transduct. Target Ther."},{"issue":"9","key":"10.1016\/j.biopha.2024.117600_bib7","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI18535","article-title":"Antimicrobial resistance: the example of Staphylococcus aureus","volume":"111","author":"Lowy","year":"2003","journal-title":"J. Clin. Invest"},{"issue":"5","key":"10.1016\/j.biopha.2024.117600_bib8","doi-asserted-by":"crossref","DOI":"10.3329\/jhpn.v29i5.8898","article-title":"Multidrug-resistant Intestinal Staphylococcus aureus among Self-medicated Healthy Adults in Amassoma, South-South, Nigeria","volume":"29","author":"Onanuga","year":"2011","journal-title":"J. Health Popul Nutr."},{"key":"10.1016\/j.biopha.2024.117600_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrmicro3380","article-title":"Molecular mechanisms of antibiotic resistance","volume":"13","author":"Blair","year":"2015","journal-title":"Nat. Rev. Microbiol"},{"issue":"3","key":"10.1016\/j.biopha.2024.117600_bib10","first-page":"137","article-title":"Antibiotic resistance mechanisms of clinically important bacteria","volume":"47","author":"Giedraitien\u0117","year":"2011","journal-title":"Med. (Kaunas. )"},{"issue":"3","key":"10.1016\/j.biopha.2024.117600_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4161\/viru.23724","article-title":"Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm","volume":"4","author":"Soto","year":"2013","journal-title":"Virulence"},{"key":"10.1016\/j.biopha.2024.117600_bib12","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41589-022-00994-9","article-title":"Structural basis for inhibition of the drug efflux pump NorA from Staphylococcus aureus","volume":"18","author":"Brawley","year":"2022","journal-title":"Nat. Chem. Biol."},{"issue":"10","key":"10.1016\/j.biopha.2024.117600_bib13","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.3389\/fmicb.2019.02762","article-title":"Clinically Approved Drugs Inhibit the Staphylococcus aureus Multidrug NorA Efflux Pump and Reduce Biofilm Formation","volume":"10","author":"Zimmermann","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.biopha.2024.117600_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1874285801307010059","article-title":"Multidrug efflux pumps in Staphylococcus aureus: an update","volume":"7","author":"Costa","year":"2013","journal-title":"Open Microbiol J."},{"issue":"2","key":"10.1016\/j.biopha.2024.117600_bib15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4274\/tjps.62207","article-title":"Pharmacological and Toxicological Properties of Eugenol","volume":"14","author":"Nejad","year":"2017","journal-title":"Turk. J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2024.117600_bib16","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.3390\/ijms22073671","article-title":"Biological properties and prospects for the application of eugenol-a review","volume":"22","author":"Ulanowska","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2024.117600_bib17","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.3390\/molecules21111595","article-title":"New thiazolyl-triazole schiff bases: synthesis and evaluation of the anti-candida potential","volume":"21","author":"Stana","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.117600_bib18","article-title":"Synthesis and biological evaluation of anti-tubercular activity of Schiff bases of 2-Amino thiazoles","volume":"30","author":"Rachel","year":"2020","journal-title":"Bioorg. Med Chem. Lett."},{"key":"10.1016\/j.biopha.2024.117600_bib19","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ejmech.2013.08.054","article-title":"2-(2-Hydrazinyl)thiazole derivatives: Design, synthesis and in vitro antimycobacterial studies","volume":"69","author":"Makam","year":"2013","journal-title":"Eur. J. Med Chem."},{"issue":"5","key":"10.1016\/j.biopha.2024.117600_bib20","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1021\/acsinfecdis.9b00357","article-title":"Liposomes for Antibiotic Encapsulation and Delivery","volume":"6","author":"Gonzalez","year":"2020","journal-title":"ACS Infect. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2024.117600_bib21","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/molecules27041372","article-title":"A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.117600_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.exppara.2013.07.022","article-title":"Liposomal-lupane system as alternative chemotherapy against cutaneous leishmaniasis: macrophage as target cell","volume":"135","author":"Barros","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.biopha.2024.117600_bib23","unstructured":"NCCLS NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that grow aerobically. 6ed. Pennsylvania, PA, USA; 2003. Available from: \u3008https:\/\/clsi.org\/media\/1632\/m07a10_sample.pdf\u3009 (accessed 10 January 2020)."},{"key":"10.1016\/j.biopha.2024.117600_bib24","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.1365-2672.1998.00379.x","article-title":"A new method for determining the minimum inhibitory concentration of essential oils","volume":"84","author":"Mann","year":"1998","journal-title":"J. Appl. Microbiol"},{"key":"10.1016\/j.biopha.2024.117600_bib25","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1128\/AAC.46.8.2720-2722.2002","article-title":"Resazurin microtiter assay plate: simple and unexpensive method for detection of drug resistance in Mycobacterium tuberculosis","volume":"46","author":"Palomino","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2024.117600_bib26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000151267","article-title":"Enhancement of the antibiotic activity against a multiresistant Escherichia coli by Mentha arvensis L. and chlorpromazine","volume":"54","author":"Coutinho","year":"2008","journal-title":"Chemotherapy"},{"key":"10.1016\/j.biopha.2024.117600_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.micpath.2017.01.019","article-title":"Cholesterol and ergosterol affect the activity of Staphylococcus aureus antibiotic efflux pumps","volume":"104","author":"Tintino","year":"2017","journal-title":"Micro Pathog."},{"issue":"2","key":"10.1016\/j.biopha.2024.117600_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2024.117600_bib29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.addr.2021.04.005","article-title":"Polymeric nano- and microparticulate drug delivery systems for treatment of biofilms","volume":"174","author":"Birk","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2024.117600_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.carbpol.2018.07.072","article-title":"Enhancing antibiofilm activity with functional chitosan nanoparticles targeting biofilm cells and biofilm matrix","volume":"200","author":"Tan","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biopha.2024.117600_bib31","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.nano.2017.03.002","article-title":"Effect of Particle Size on the Biodistribution, Toxicity, and Efficacy of Drug-Loaded Polymeric Nanoparticles in Chemoradiotherapy","volume":"13","author":"Caster","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2024.117600_bib32","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.colsurfb.2016.03.013","article-title":"Time to Overcome Fluconazole Resistant Candida Isolates: Solid Lipid Nanoparticles as a Novel Antifungal Drug Delivery System","volume":"142","author":"Moazeni","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biopha.2024.117600_bib33","first-page":"345","article-title":"Development and Validation of a Method for Determination of Encapsulation Efficiency of CPT-11\/DSPE-MPEG2000 Nanoparticles","volume":"6","author":"Li","year":"2016","journal-title":"Med Chem. Open Access J."},{"key":"10.1016\/j.biopha.2024.117600_bib34","first-page":"265","article-title":"Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems\u2014A Review (Part 2)","volume":"12","author":"Honary","year":"2013","journal-title":"Trop. J. Pharm. Res"},{"key":"10.1016\/j.biopha.2024.117600_bib35","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1007\/s00216-017-0527-z","article-title":"Zeta potential: a case study of cationic, anionic, and neutral liposomes","volume":"409","author":"Smith","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"issue":"n. 31","key":"10.1016\/j.biopha.2024.117600_bib36","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1016\/j.biomaterials.2007.07.029","article-title":"Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential","volume":"v. 28","author":"Patil","year":"2007","journal-title":"Biomaterials"},{"issue":"n. 1-2","key":"10.1016\/j.biopha.2024.117600_bib37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0168-3659(01)00389-3","article-title":"Drug physical state and drug\u2013polymer interaction on drug release from chitosan matrix films","volume":"v. 75","author":"Puttipipatkhachorn","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2024.117600_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of Nanoparticle Delivery to Tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"issue":"1","key":"10.1016\/j.biopha.2024.117600_bib39","first-page":"123","article-title":"ADMET Analysis, Antibacterial and Modified Antibiotic Activities of Thiadiazine Derivatives","volume":"38","author":"Freitas","year":"2024","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.biopha.2024.117600_bib40","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3390\/molecules28041819","article-title":"Efflux Pump (QacA, QacB, and QacC) and \u03b2-Lactamase Inhibitors? An Evaluation of 1,8-Naphthyridines against Staphylococcus aureus Strains","volume":"28","author":"Oliveira-Tintino","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.117600_bib41","doi-asserted-by":"crossref","unstructured":"A.C.J d Ara\u00fajo, P.R. Freitas, I.M Ara\u00fajo, G.M Siqueira, J.A d Oliveira-Borges, D.S. Alves, G.M. Miranda, I.J.S. Nascimento, J.X. d Ara\u00fajo-J\u00fanior, E.F. d Silva-J\u00fanior, T.M. d Aquino, F.J.B.M. Junior, E.S. Marinho, H.S dos Santos, S.R. Tintino, H.D.M. Coutinho. Potentiating-antibiotic activity and absorption, distribution, metabolism, excretion and toxicity properties (ADMET) analysis of synthetic thiadiazines against multi-drug resistant (MDR) strains, 2024 Pages 84-98.","DOI":"10.1111\/fcp.12950"},{"key":"10.1016\/j.biopha.2024.117600_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2023.101162","article-title":"Effect of gallium and strontium salts on the characteristics and biological applications of Sr and Ga-modified titanate nanotubes","volume":"6","author":"Pereira","year":"2023","journal-title":"Results Chem."},{"key":"10.1016\/j.biopha.2024.117600_bib43","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3390\/antibiotics9050247","article-title":"GC-MS Profile and Enhancement of Antibiotic Activity by the Essential Oil of Ocotea odor\u00edfera and Safrole: Inhibition of Staphylococcus aureus Efflux Pumps","volume":"9","author":"Almeida","year":"2020","journal-title":"Antibiotics"},{"issue":"4","key":"10.1016\/j.biopha.2024.117600_bib44","article-title":"Enhanced antibacterial effect of antibiotics by the essential oil of Aloysia gratissima (Gillies & Hook.) Tronc. and its major constituent beta-caryophyllene","volume":"1","author":"Santos","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2024.117600_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2019.02.045","article-title":"Synthesis, chemical characterization and antimicrobial activity of new acylhydrazones derived from carbohydrates","author":"Guilherme","year":"2019","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.biopha.2024.117600_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2015.04.002","article-title":"Synthesis and antimicrobial activity of 6-triazolo-6-deoxy eugenol glucosides","author":"de Souza","year":"2015","journal-title":"Carbohydr. Res"},{"issue":"2","key":"10.1016\/j.biopha.2024.117600_bib47","first-page":"201","volume":"41","author":"Cukurovali","year":"2006","journal-title":"Synth., Antibact. Antifung. Act. some N. thiazolylhydrazone Deriv. Contain. 3-Substit. cyclobutane ring"},{"issue":"4","key":"10.1016\/j.biopha.2024.117600_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jscs.2022.101488","article-title":"Design, synthesis and docking studies of new hydrazinyl-thiazole derivatives as anticancer and antimicrobial agents","volume":"26","author":"El-Naggar","year":"2022","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.biopha.2024.117600_bib49","first-page":"467","article-title":"Synthesis, antioxidant, antimicrobial and antiviral docking studies of ethyl 2-(2-(arylidene)hydrazinyl)thiazole-4-carboxylates","volume":"76","author":"Haroon","year":"2021","journal-title":"Z. Nat. C."},{"issue":"5","key":"10.1016\/j.biopha.2024.117600_bib50","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1248\/cpb.59.568","article-title":"Synthesis, Antibacterial Activity and Quantum-Chemical Studies of Novel 2-Arylidenehydrazinyl-4-arylthiazole Analogues","volume":"59","author":"Alam","year":"2011","journal-title":"Chem. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.biopha.2024.117600_bib51","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00239-019-09914-3","article-title":"Antimicrobial resistance in bacteria: mechanisms, evolution, and persistence","volume":"88","author":"Christaki","year":"2020","journal-title":"J. Mol. Evol."},{"key":"10.1016\/j.biopha.2024.117600_bib52","series-title":"Microbiologia","author":"Tortora","year":"2017"},{"key":"10.1016\/j.biopha.2024.117600_bib53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.micpath.2016.04.003","article-title":"Evaluation of the tannic acid inhibitory effect against the NorA efflux pump of Staphylococcus aureus","volume":"97","author":"Tintino","year":"2016","journal-title":"Micro Pathog."},{"key":"10.1016\/j.biopha.2024.117600_bib54","first-page":"11","article-title":"Staphylococcus aureus: Overview of Bacteriology, Clinical Diseases, Epidemiology, Antibiotic Resistance and Therapeutic Approach","author":"Gnanamani","year":"2017","journal-title":"Front. Staphylococcus aureus"},{"issue":"9","key":"10.1016\/j.biopha.2024.117600_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201800141","article-title":"Recent updates of fluoroquinolones as antibacterial agents","volume":"351","author":"Ezelarab","year":"2018","journal-title":"Arch. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2024.117600_bib56","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/antibiotics7020032","article-title":"Our evolving understanding of the mechanism of quinolones","volume":"7","author":"Gutierrez","year":"2018","journal-title":"Antibiotics"},{"issue":"14","key":"10.1016\/j.biopha.2024.117600_bib57","doi-asserted-by":"crossref","first-page":"9401","DOI":"10.1074\/jbc.272.14.9401","article-title":"Mechanism of quinolone action. A drug-induced structural perturbation of the DNA precedes strand cleavage by topoisomerase IV","volume":"272","author":"Marians","year":"1997","journal-title":"J. Biol. Chem."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224014860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224014860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:52:23Z","timestamp":1773967943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224014860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":57,"alternative-id":["S0753332224014860"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117600","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liposomal formulation with thiazolic compounds against bacterial efflux pumps","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117600","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117600"}}